| pubmed-article:18415829 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C2926606 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0066700 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C2607943 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0205081 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0117996 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C1960048 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C1967611 | lld:lifeskim |
| pubmed-article:18415829 | lifeskim:mentions | umls-concept:C0149783 | lld:lifeskim |
| pubmed-article:18415829 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18415829 | pubmed:dateCreated | 2008-4-16 | lld:pubmed |
| pubmed-article:18415829 | pubmed:abstractText | Inhaled corticosteroids (ICSs) are one of the suggested first-line therapies for patients with persistent asthma of moderate severity. | lld:pubmed |
| pubmed-article:18415829 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18415829 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18415829 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18415829 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18415829 | pubmed:issn | 1532-4303 | lld:pubmed |
| pubmed-article:18415829 | pubmed:author | pubmed-author:PriceDavidD | lld:pubmed |
| pubmed-article:18415829 | pubmed:author | pubmed-author:SussmanGordon... | lld:pubmed |
| pubmed-article:18415829 | pubmed:author | pubmed-author:HarnestUlfU | lld:pubmed |
| pubmed-article:18415829 | pubmed:author | pubmed-author:HowesTimT | lld:pubmed |
| pubmed-article:18415829 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18415829 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:18415829 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18415829 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18415829 | pubmed:pagination | 215-20 | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:meshHeading | pubmed-meshheading:18415829... | lld:pubmed |
| pubmed-article:18415829 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18415829 | pubmed:articleTitle | Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. | lld:pubmed |
| pubmed-article:18415829 | pubmed:affiliation | Institute for Medical Treatment Strategies, Munich, Germany. dr.med.u.harnest@onlinemed.de | lld:pubmed |
| pubmed-article:18415829 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18415829 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:18415829 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18415829 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
